Good practice guide
Supporting community action on HIV, health and rights to end AIDS
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Chapter 8, Prison and Health, published
PLOS ONE | DOI:10.1371/journal.pone.0155525 May 19, 2016, 1 / 11
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
The TB section of the toolkit presents selected (a) programmatic output and (b) outcome and impact indicators for TB. In addition to recommended monitoring programs and measuring the outcomes and impact of TB programs, indicators for the strengthening of health systems, strengthening of community sy...stems and some indicators that measure quality of services are also included.
more
The Open Infectious Diseases Journal, 2010, 4, 33-37
Key Populations Brief
Accessed November 2017